Patent Assignment
Reel/Frame 069325/0179
Assignment of Assignor's Interest
Recorded: 2024-11-07
Pages: 20
Assignor
WELLSPRING BIOSCIENCES, INC.
Executed: 2014-10-01
Assignee
KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CALIFORNIA, 92130
Covered Properties
(53)
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
PCT:
PCT/US2015/048957 ↗
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
PCT:
PCT/US2016/022717 ↗
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
PCT:
PCT/US2016/035869 ↗
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
PCT:
PCT/US2017/022535 ↗
Substituted Inhibitors of Menin-Mll and Methods of Use
PCT:
PCT/US2017/022564 ↗
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
PCT:
PCT/US2018/023804 ↗
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
PCT:
PCT/US2018/036485 ↗
Substituted Inhibitors of Menin-Mll and Methods of Use
PCT:
PCT/US2018/051666 ↗
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Substituted Inhibitors of Menin-Mll and Methods of Use
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Substituted Inhibitors of Menin-Mll and Methods of Use
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Substituted Inhibitors of Menin-Mll and Methods of Use
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
Patent:
49,687 →
Application:
17/165,794 →
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Application:
18/056,539 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/150,137 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
18/181,328 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/185,936 →
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
Application:
18/418,061 →
Publication:
US 2024/0358703
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
18/487,000 →
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Application:
18/490,078 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/501,866 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/543,945 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
18/674,546 →
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Application:
18/735,978 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/744,026 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
18/814,217 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
62/171,108 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
62/171,111 →
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
Application:
62/171,124 →
Thienopyrimidine and Thienopyridine Compounds and Methods of Use Thereof
Application:
62/214,681 →
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Application:
62/309,362 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/309,372 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/334,369 →
Bridged Bicyclic Inhibitors of Menin-Mll and Methods of Use
Application:
62/431,387 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/431,389 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/446,640 →
Methods for Treating Acute Myeloid Leukemia or Ewing's Sarcoma
Application:
62/476,710 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
62/517,041 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/561,089 →
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
Application:
62/561,119 →
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
Application:
62/577,640 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/577,644 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/595,436 →
Methods for Treating Hematological Malignancies and Ewing's Sarcoma
Application:
62/635,256 →
Methods and Compositions for Inhibiting the Interaction of Menin with Mll Proteins
Application:
62/636,976 →
Substituted Inhibitors of Menin-Mll and Methods of Use
Application:
62/637,074 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 21, 2016
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 038978/0380 →
Assignment of Assignor's Interest
Jun 21, 2016
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 039113/0391 →
Assignment of Assignor's Interest
Jan 24, 2017
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 041469/0355 →
Assignment of Assignor's Interest
Jan 24, 2017
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 041062/0613 →
Assignment of Assignor's Interest
Mar 15, 2017
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 041584/0843 →
Assignment of Assignor's Interest
Aug 10, 2017
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 043264/0015 →
Assignment of Assignor's Interest
Aug 11, 2017
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 043267/0369 →
Corrective Assignment to Correct the Application Number 15/059,989 Previously Recorded on Reel 043267 Frame 0369. Assignor(S) Hereby Confirms the Assignment of Assignors Interest.
Aug 16, 2017
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 044068/0719 →
Assignment of Assignor's Interest
Aug 22, 2017
From: WU, TAO; LI, LIANSHENG; WANG, YI; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 043358/0121 →
Assignment of Assignor's Interest
Aug 22, 2017
From: WU, TAO; LI, LIANSHENG; WANG, YI; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 043358/0220 →
Assignment of Assignor's Interest
Sep 8, 2017
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; KLOSSOWSKI, SZYMON; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 043530/0780 →
Assignment of Assignor's Interest
Sep 8, 2017
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; KLOSSOWSKI, SZYMON; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 043530/0833 →
Assignment of Assignor's Interest
Dec 15, 2017
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 044407/0666 →
Assignment of Assignor's Interest
Jan 25, 2018
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 044727/0321 →
Assignment of Assignor's Interest
Mar 26, 2018
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 045350/0217 →
Assignment of Assignor's Interest
Apr 5, 2018
From: BURROWS, FRANCIS; KESSLER, LINDA V.; LI, LIANSHENG; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 045446/0269 →
Assignment of Assignor's Interest
May 1, 2018
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 045678/0345 →
Assignment of Assignor's Interest
Jul 18, 2018
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 046390/0540 →
Assignment of Assignor's Interest
Aug 3, 2018
From: LI, LIANSHENG; WU, TAO; FENG, JUN; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 046554/0726 →
Assignment of Assignor's Interest
Aug 3, 2018
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; KLOSSOWSKI, SZYMON; BORKIN, DMITRY
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 046554/0779 →
Assignment of Assignor's Interest
Sep 14, 2018
From: GREMBECKA, JOLANTA; CIERPICKI, TOMASZ; BORKIN, DMITRY; POLLOCK, JONATHAN
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 046876/0827 →
Assignment of Assignor's Interest
Oct 24, 2018
From: WU, TAO; LI, LIANSHENG; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 047300/0405 →
Assignment of Assignor's Interest
Nov 12, 2018
From: WU, TAO; LI, LIANSHENG; WANG, YI; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 047478/0216 →
Assignment of Assignor's Interest
Nov 12, 2018
From: WU, TAO; LI, LIANSHENG; WANG, YI; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 047478/0192 →
Assignment of Assignor's Interest
Nov 19, 2018
From: WU, TAO; LI, LIANSHENG; REN, PINGDA
To: KURA ONCOLOGY, INC.
Reel/Frame 047548/0211 →